高危男性乳腺癌筛查:男性乳腺影像检查使用与结局的12年纵向观察研究
该回顾性研究分析2005至2017年12年间1869名男性的2052次乳腺影像检查,其中筛查检查271次(13.2%),诊断检查1781次(86.8%)。筛查发现5例淋巴结阴性癌,癌症检出率18/1000次检查(95%CI:7,41),乳腺X线筛查敏感度100%(95%CI:50%,100%)、特异度95.0%(95%CI:93.1%,98%)。高龄、德系犹太人血统、基因突变、个人史和一级家族史与乳腺癌相关。
要点
- 高危男性筛查乳腺X线癌症检出率18/1000次(95%CI:7,41),平均筛查4人年后诊断。
- 筛查乳腺X线敏感度100%(95%CI:50%,100%)、特异度95.0%(95%CI:93.1%,98%)。
- 高龄、德系犹太人血统、基因突变、个人史和一级家族史与乳腺癌相关。
核心结论
- 对乳腺癌高危男性进行筛查可能存在获益,此类筛查可能随时间增加。
研究设计与样本
- 回顾性研究,连续纳入2005至2017年12年间的男性乳腺影像检查。
- 共1869名男性(中位年龄55岁,范围18-96岁)接受2052次检查,发现2304个乳腺病灶。
- 共149次(6.5%)活检(涉及133名男性),其中41次(27.5%)恶性、108次(72.5%)良性。
- 检查包括1781次(86.8%)诊断性检查和271次(13.2%)筛查检查;所有接受筛查的男性均有乳腺癌个人史或家族史和/或基因突变。
- 统计分析采用Fisher精确检验、Mann-Whitney检验、Spearman相关和logistic回归。
诊断标准与关键数值
- 筛查乳腺X线发现5例淋巴结阴性癌,癌症检出率18/1000次检查(95%CI:7,41),癌症平均在筛查4人年后诊断(范围1-10人年)。
- 乳腺X线筛查敏感度100%(95%CI:50%,100%)、特异度95.0%(95%CI:93.1%,98%)、活检阳性预测值50%(95%CI:22.2%,77.8%)。
- 高龄(P < .001)、德系犹太人血统(P < .001)、基因突变(P = .006)、个人史(P < .001)和一级家族史(P = .03)与乳腺癌相关;非一级家族史与癌症无关(P = .09)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Male breast cancer incidence is rising. There may be a potential role in selective screening in men at elevated risk for breast cancer, but the effectiveness of such screening remains unexplored. Purpose To evaluate patterns of male breast imaging utilization, to determine high-risk screening outcomes, and to delineate risk factors associated with cancer diagnosis. Materials and Methods This retrospective study reviewed consecutive male breast imaging examinations over a 12-year period (between 2005-2017). Examination indications, biopsy recommendations, and pathologic results were correlated with patient characteristics. Fisher exact test, Mann-Whitney test, Spearman correlation, and logistic regression were used for statistical analysis. Results A total of 1869 men (median age, 55 years; range, 18-96 years) underwent 2052 examinations yielding 2304 breast lesions and resulting in 149 (6.5%) biopsies in 133 men; 41 (27.5%) were malignant and 108 (72.5%) were benign. There were 1781 (86.8%) diagnostic and 271 (13.2%) screening examinations. All men undergoing screening had personal or family history of breast cancer and/or genetic mutations. There was a significant increase in the number of examinations in men relative to the number of examinations in women over time (Spearman correlation, r = 0.85; P < .001). Five node-negative cancers resulted from screening mammography, yielding a cancer detection rate of 18 per 1000 examinations (95% confidence interval [CI]: 7, 41), with cancers diagnosed on average after 4 person-years of screening (range, 1-10 person-years). Mammographic screening sensitivity, specificity, and positive predictive value of biopsy were 100% (95% CI: 50%, 100%), 95.0% (95% CI: 93.1%, 98%), and 50% (95% CI: 22.2%, 77.8%). Older age (P < .001), Ashkenazi descent (P < .001), genetic mutations (P = .006), personal history (P < .001), and first-degree family history (P = .03) were associated with breast cancer. Non-first-degree family history was not associated with cancer (P = .09). Conclusion There is potential benefit in screening men at high risk for developing breast cancer. Such screening may have increased over time. © RSNA, 2019.
引用
- Gao Y, Goldberg JE, Young TK, et al. Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes. Radiology. 2019. PMID: 31526252. doi:10.1148/radiol.2019190971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。